Real, J., Vlacho, B., Ortega, E., Vallés, J. A., Mata-Cases, M., Castelblanco, E., . . . Franch-Nadal, J. (2021). Cardiovascular and mortality benefits of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus.
Citación estilo ChicagoReal, Jordi|||0000-0002-5979-8948, et al. Cardiovascular and Mortality Benefits of Sodium-glucose Co-transporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus. 2021.
Cita MLAReal, Jordi|||0000-0002-5979-8948, et al. Cardiovascular and Mortality Benefits of Sodium-glucose Co-transporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus. 2021.
Precaución: Estas citas no son 100% exactas.